Related by context. Frequent words. (Click for all words.) 77 Suppl 76 #:#-# [023] 75 #:#-# [031] 75 Arch Neurol 74 Abstract Number 74 Meta Analysis 73 Free Full Text 73 Abstract Full Text 73 Cancer Res 72 Clinical Trial Results 72 Drug Candidate 72 Immunol 72 #:#-# [037] 72 Chronic Hepatitis C 72 CrossRef Medline 72 Dermatol 72 Oncol 72 J Am Coll 71 #:#-# [033] 71 Systemic Lupus Erythematosus 71 #:#-# [029] 71 Systematic Review 71 Abstract Free Full Text 71 Int J 71 #:#-# [001] 71 Oral Presentation 70 Lenalidomide 70 suppl 70 J Clin Oncol 70 #:#-# [006] 70 J Am Acad 69 Cardiol 69 #:#-# [035] 69 Natalizumab 69 Am J Clin 69 Overactive Bladder 69 Oncogene 69 Immunogenicity 69 Autoimmune Diseases 69 J Natl Cancer Inst 69 #:#-# [025] 69 Biol 69 Arch Intern Med 69 #:#-# [028] 69 Benign Prostatic Hyperplasia 69 Inhibits 68 Heart Failure Patients 68 #-# Abstract Full [001] 68 Pathogenesis 68 S# S# [001] 68 #-# Abstract Full [002] 68 Chronic Lymphocytic Leukemia 68 Metastatic Melanoma 68 Combination Therapy 68 PMID # [002] 67 Low Dose 67 Monoclonal Antibody 67 Ischemic 67 Ann Intern Med 67 Elderly Patients 67 J Biol Chem 67 Postmenopausal Women 67 Psychol 67 Solid Tumors 67 #:#-# [022] 66 Proc Natl Acad Sci 66 Patients Treated 66 Nutr 66 Crit Care Med 66 #:#-# [016] 66 #:#-# [002] 66 Clin Infect Dis 66 Am J Respir 66 Advanced Prostate Cancer 66 J Clin Psychiatry 66 Small Molecule 66 Randomized Controlled Trial 66 Bladder Cancer 65 Poster Presentation 65 Microbiol 65 Biol Psychiatry 65 e# [005] 65 Asymptomatic 65 Irinotecan 65 Phase III Clinical Trial 65 Induces 65 Insulin Resistance 65 FDA Clears 65 Erlotinib 65 J Med 65 N Engl J 65 Pulmonary Arterial Hypertension 65 #:#-# [027] 64 Autoimmunity 64 Hepatitis C Virus 64 Phase III Trial 64 Completes Enrollment 64 Prophylaxis 64 Am J Physiol 64 Bevacizumab 64 Bortezomib